Prehabilitation is feasible in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy and may minimize physical deterioration: results from The REx trial

S. J. Moug, N. Mutrie, S. J. E. Barry, G. Mackay, R. J. C. Steele, C. Boachie, C. Buchan, A. S. Anderson

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)
3 Downloads (Pure)

Fingerprint Dive into the research topics of 'Prehabilitation is feasible in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy and may minimize physical deterioration: results from The REx trial'. Together they form a unique fingerprint.